Register for October 5th Forum Honoring Prize Competition Winners for Enhancing Faculty Gender Diversity
The forum will present the winners' effective, evidence-based practices and feature four panels exploring challenges and discussing ways to improve the existing career paradigm for many women in biomedical and behavioral science.
ORWH Recognizes Polycystic Ovary Syndrome Awareness Month
ORWH developed a polycystic ovary/ovarian syndrome (PCOS) booklet to help bring awareness to and enhance the lives of those affected by PCOS.
NOSI on Interventions Designed to Change the Culture to Mitigate or Eliminate Sexual Harassment in the Biomedical Research Enterprise
NIH is encouraging applications to test interventions aiming to lessen or eliminate sexual harassment in the biomedical research enterprise. Submit an application for this notice of special interest (NOSI) on October 13, 2021.
Read In Focus
ORWH’s In Focus Publication Explores Gynecological Cancer Research
The latest issue of Women’s Health in Focus at NIH explores NIH’s efforts to improve the screening, prevention, and treatment of gynecological cancers. Additional articles in this issue describe efforts by ORWH and others to improve gender diversity and parity throughout the biomedical and biobehavioral research workforce and other topics relevant to the health of women and women in biomedical careers.
ORWH's E-Learning Courses
Gain an up-to-date understanding of sex and gender influences on health and disease and NIH requirements on factoring sex as a biological variable into research designs through three online courses.
ORWH Women, Science, and the Impact of COVID-19 Webpage
This webpage describes: (1) NIH efforts to ensure that research on COVID-19 appropriately incorporates consideration of sex and gender influences; (2) the pandemic’s effects on the careers of women in STEMM fields and biomedical researchers and how NIH is supporting them; and (3) the NIH-Wide Strategic Plan for COVID-19 Research and how it intersects with ORWH’s mission areas.
Janine Austin Clayton, M.D., FARVO
Janine Austin Clayton, M.D., FARVO, was appointed Associate Director for Research on Women’s Health and Director of the Office of Research on Women’s Health at the National Institutes of Health (NIH) in 2012. Dr. Clayton has strengthened NIH support for research on diseases, disorders, and conditions that affect women. She is the architect of the NIH policy requiring scientists to consider sex as a biological variable across the research spectrum, including research designs, analyses, and reporting in vertebrate animal and human studies. The policy serves as keystone of initiative to enhance research reproducibility, rigor NIH’s, and transparency.
Featured NIH-Wide Resources & Initiatives
A public-private partnership to develop a coordinated research strategy to speed the most promising COVID-19 vaccines and treatments.
A new science agency proposed by President Joseph Biden as part of NIH to drive biomedical breakthroughs and provide transformative solutions for all patients.
A research effort to revolutionize how we improve health and treat disease.
A bold venture to help identify new treatments and cures for diseases.
An initiative to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.
NIH does not tolerate pervasive or severe harassment of any kind, including sexual harassment.
Trans-agency effort to speed scientific solutions to stem the national opioid crisis.
NIH-supported research has had a major positive impact on nearly all of our lives.
A new research initiative to understand, prevent, and treat the long-term effects of COVID-19.
Learn more about NIH’s efforts to end structural racism in biomedical research through the UNITE initiative.
Learn about participating in clinical trials and where to find them.
Important initiatives aimed at improving medical research.